36893588|t|Cytotoxic CD161-CD8+ TEMRA cells contribute to the pathogenesis of systemic lupus erythematosus.
36893588|a|BACKGROUND: Systemic lupus erythematosus (SLE) is a prototypical autoimmune disease affecting multiple organs and tissues with high cellular heterogeneity. CD8+ T cell activity is involved in the SLE pathogenesis. However, the cellular heterogeneity and the underlying mechanisms of CD8+ T cells in SLE remain to be identified. METHODS: Single-cell RNA sequencing (scRNA-seq) of PBMCs from a SLE family pedigree (including 3 HCs and 2 SLE patients) was performed to identify the SLE-associated CD8+ T cell subsets. Flow cytometry analysis of a SLE cohort (including 23 HCs and 33 SLE patients), qPCR analysis of another SLE cohort (including 30 HCs and 25 SLE patients) and public scRNA-seq datasets of autoimmune diseases were employed to validate the finding. Whole-exome sequencing (WES) of this SLE family pedigree was used to investigate the genetic basis in dysregulation of CD8+ T cell subsets identified in this study. Co-culture experiments were performed to analyze the activity of CD8+ T cells. FINDINGS: We elucidated the cellular heterogeneity of SLE and identified a new highly cytotoxic CD8+ T cell subset, CD161-CD8+ TEMRA cell subpopulation, which was remarkably increased in SLE patients. Meanwhile, we discovered a close correlation between mutation of DTHD1 and the abnormal accumulation of CD161-CD8+ TEMRA cells in SLE. DTHD1 interacted with MYD88 to suppress its activity in T cells and DTHD1 mutation promoted MYD88-dependent pathway and subsequently increased the proliferation and cytotoxicity of CD161-CD8+ TEMRA cells. Furthermore, the differentially expressed genes in CD161-CD8+ TEMRA cells displayed a strong out-of-sample prediction for case-control status of SLE. INTERPRETATION: This study identified DTHD1-associated expansion of CD161-CD8+ TEMRA cell subpopulation is critical for SLE. Our study highlights genetic association and cellular heterogeneity of SLE pathogenesis and provides a mechanistical insight into the diagnosis and treatment of SLE. FUNDINGS: Stated in the Acknowledgements section of the manuscript.
36893588	10	15	CD161	Gene	3820
36893588	16	19	CD8	Gene	925
36893588	67	95	systemic lupus erythematosus	Disease	MESH:D008180
36893588	109	137	Systemic lupus erythematosus	Disease	MESH:D008180
36893588	139	142	SLE	Disease	MESH:D008180
36893588	162	180	autoimmune disease	Disease	MESH:D001327
36893588	253	256	CD8	Gene	925
36893588	293	296	SLE	Disease	MESH:D008180
36893588	380	383	CD8	Gene	925
36893588	396	399	SLE	Disease	MESH:D008180
36893588	489	492	SLE	Disease	MESH:D008180
36893588	532	535	SLE	Disease	MESH:D008180
36893588	536	544	patients	Species	9606
36893588	576	579	SLE	Disease	MESH:D008180
36893588	591	594	CD8	Gene	925
36893588	641	644	SLE	Disease	MESH:D008180
36893588	677	680	SLE	Disease	MESH:D008180
36893588	681	689	patients	Species	9606
36893588	717	720	SLE	Disease	MESH:D008180
36893588	753	756	SLE	Disease	MESH:D008180
36893588	757	765	patients	Species	9606
36893588	800	819	autoimmune diseases	Disease	MESH:D001327
36893588	896	899	SLE	Disease	MESH:D008180
36893588	978	981	CD8	Gene	925
36893588	1089	1092	CD8	Gene	925
36893588	1157	1160	SLE	Disease	MESH:D008180
36893588	1199	1202	CD8	Gene	925
36893588	1219	1224	CD161	Gene	3820
36893588	1225	1228	CD8	Gene	925
36893588	1290	1293	SLE	Disease	MESH:D008180
36893588	1294	1302	patients	Species	9606
36893588	1369	1374	DTHD1	Gene	401124
36893588	1408	1413	CD161	Gene	3820
36893588	1414	1417	CD8	Gene	925
36893588	1434	1437	SLE	Disease	MESH:D008180
36893588	1439	1444	DTHD1	Gene	401124
36893588	1461	1466	MYD88	Gene	4615
36893588	1507	1512	DTHD1	Gene	401124
36893588	1531	1536	MYD88	Gene	4615
36893588	1620	1625	CD161	Gene	3820
36893588	1626	1629	CD8	Gene	925
36893588	1695	1700	CD161	Gene	3820
36893588	1701	1704	CD8	Gene	925
36893588	1789	1792	SLE	Disease	MESH:D008180
36893588	1832	1837	DTHD1	Gene	401124
36893588	1862	1867	CD161	Gene	3820
36893588	1868	1871	CD8	Gene	925
36893588	1914	1917	SLE	Disease	MESH:D008180
36893588	1990	1993	SLE	Disease	MESH:D008180
36893588	2080	2083	SLE	Disease	MESH:D008180
36893588	Association	3820	401124
36893588	Association	MESH:D008180	3820
36893588	Association	401124	925
36893588	Association	MESH:D008180	925
36893588	Association	MESH:D008180	401124
36893588	Association	3820	925
36893588	Association	401124	4615

